Natural products to drugs: daptomycin and related lipopeptide antibiotics.
about
Combinatorial biosynthesis of novel antibiotics related to daptomycinEvaluation of Biosynthetic Pathway and Engineered Biosynthesis of AlkaloidsCyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteriaAnnotating Enzymes of Uncertain Function: The Deacylation of d -Amino Acids by Members of the Amidohydrolase Superfamily ,Chemical structure, property and potential applications of biosurfactants produced by Bacillus subtilis in petroleum recovery and spill mitigationThe Melanocortin Receptor System: A Target for Multiple Degenerative DiseasesDaptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responsesMinutissamides E-L, antiproliferative cyclic lipodecapeptides from the cultured freshwater cyanobacterium cf. Anabaena sp.Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporusNew pleiotropic effects of eliminating a rare tRNA from Streptomyces coelicolor, revealed by combined proteomic and transcriptomic analysis of liquid culturesScreen for inducers of autolysis in Bacillus subtilisGenetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.Revealing the first uridyl peptide antibiotic biosynthetic gene cluster and probing pacidamycin biosynthesisIdentification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolomeGenetics of antimicrobial resistance in Staphylococcus aureus.Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens.Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptidePhylogenetic relatedness determined between antibiotic resistance and 16S rRNA genes in actinobacteria.Back to the future: a new 'old' lead for tuberculosis.β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci.The evolution of gene collectives: How natural selection drives chemical innovation.The isotridecanyl side chain of plusbacin-A3 is essential for the transglycosylase inhibition of peptidoglycan biosynthesisSynthetic lipopeptides: a novel class of anti-infectives.Design and Synthesis of Molecular Scaffolds with Anti-infective Activity.Solid-state NMR characterization of amphomycin effects on peptidoglycan and wall teichoic acid biosyntheses in Staphylococcus aureus.How nature morphs peptide scaffolds into antibioticsThe structural diversity of acidic lipopeptide antibiotics.Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.MS/MS-based networking and peptidogenomics guided genome mining revealed the stenothricin gene cluster in Streptomyces roseosporus.Selective in vivo and in vitro activities of 3,3'-4-nitrobenzylidene-bis-4-hydroxycoumarin against methicillin-resistant Staphylococcus aureus by inhibition of DNA polymerase III.Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machineryRoad to clinical efficacy: challenges and novel strategies for antimicrobial peptide development.Recent derivatives from smaller classes of fermentation-derived antibacterials.The Interplay between Daptomycin and the Immune System.Bacterial synthesis of D-amino acids.Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.Recent advances in combinatorial biosynthesis for drug discovery
P2860
Q24676630-85FAD3F0-9D2F-42C3-B412-4D7594BEE94EQ26739981-04FF42AF-8D28-4EF3-ADAB-FC896C897FDAQ26863225-3ED210B2-37ED-4AA8-B3BD-127E84104546Q27655879-72F2E1FA-0711-42B8-A8EA-53FCD5FFF71BQ28083697-8AA5256B-71CF-4818-BF66-921611423145Q28273671-481F586B-5ECA-4F84-A8BC-84D8A50B4F00Q28754911-87911E0E-D926-423F-A524-04EB92E7D85EQ30565890-A73DC633-603B-4FEA-991B-941F5F11B208Q31038560-0ABBC12B-337A-4237-895D-D5EDA853D0F3Q33293232-DF0477A8-9B18-45BB-AEFE-FF93BCEF05F0Q33626330-7F89B104-1171-43A0-967A-A9E0814545CDQ33768851-6E59D8E7-1E9A-49AC-89AA-D15953951593Q33987287-DE2719C0-0CD8-4552-8B54-F56917599159Q34022733-554EE0C4-BCBB-4864-9B55-59290612A5D0Q34959567-3C5E9F5C-436E-4C05-82CC-5B0D4B11D7DDQ34984662-EF7B734D-8A15-4029-B93E-46018032025CQ35190498-04650D54-CC58-4B3B-B327-B209AF2375F4Q35224649-2BE2017D-3233-41B8-A7A9-A773C8665F47Q35344586-A3CC9C40-8CC0-4421-83E9-5E1C018599ADQ36379530-20280A1F-3B52-4269-9548-0E83DC67FA35Q36396117-D17595A3-77D8-4567-B44D-199C655D4A12Q36505466-F27F04A1-5E6E-41C6-ADE0-C71F768C0125Q36534513-D8C110AE-BC71-485B-A842-64B77D03B7EAQ36773407-92344A33-0E5C-4141-ACF0-1980D9071C7EQ36904839-F4F006CA-B5D7-48CC-87F2-86D8CEB90B82Q36972421-C40C08DC-707B-4EAD-9965-7915DD160A51Q37188973-0CF87310-968D-4D24-9F2E-3E973A9B1472Q37341890-B8DCBB2A-5830-40BA-87DE-45A5A9757108Q37373526-CA7F9FFA-A3CC-4243-B124-4E687120D943Q37417749-4FAC15BC-3670-4DB5-8D41-3A1044EEED12Q37538754-55B4BD71-7084-493C-9464-B047AC83CFAAQ37572589-EA84D60B-AAA3-4FFC-8F19-7743C0A96768Q37736231-6FD1DF32-9553-4D37-82EA-575C4B2B3777Q37762644-03BEAF8F-2A2C-4519-8E7B-6BD0626BB986Q37894693-0E31DFC8-2A08-4D46-8B25-B34CDAD91A8FQ37964009-4AC53C41-2B89-40E6-9F4E-257DACE988BFQ38191612-FE8C53D0-EDD2-4694-9C52-FA6E0626D46FQ38206149-BFEC4B50-8128-4F28-B745-B0EC0FC010BCQ38264138-66761619-7723-476B-8665-86CBD097F9AAQ38364681-BEF46F4D-EC7D-4BF3-B81D-B219FC751B46
P2860
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@ast
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@en
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@nl
type
label
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@ast
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@en
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@nl
prefLabel
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@ast
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@en
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@nl
P2093
P2860
P356
P1476
Natural products to drugs: daptomycin and related lipopeptide antibiotics.
@en
P2093
Richard H Baltz
Stephen K Wrigley
Vivian Miao
P2860
P304
P356
10.1039/B416648P
P577
2005-11-04T00:00:00Z